相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic factors for stage III epithelial ovarian cancer: A Gynecologic Oncology Group Study
William E. Winter et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Ovarian clear cell adenocarcinoma: a continuing enigma
David S. P. Tan et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Lifetime ovulatory cycles and ovarian cancer risk in 2 Italian case-control studies
Claudio Pelucchi et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Etiology and pathogenesis of epithelial ovarian cancer
Samuel C. Mok et al.
DISEASE MARKERS (2007)
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Y. Lee et al.
JOURNAL OF PATHOLOGY (2007)
Genomics and proteomics: Emerging technologies in clinical cancer research
Christine H. Chung et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Gene expression profiling of human ovarian tumours
S. Biade et al.
BRITISH JOURNAL OF CANCER (2006)
Clinical characteristics and prognosis of mucinous tumors of the ovary
Fumitaka Kikkawa et al.
GYNECOLOGIC ONCOLOGY (2006)
Diagnosis and management of epithelial ovarian cancer
Snehal Bhoola et al.
OBSTETRICS AND GYNECOLOGY (2006)
Ovarian epithelial tumors of low malignant potential: Are they precursors of ovarian carcinoma?
M Fukumoto et al.
PATHOLOGY INTERNATIONAL (2006)
A distinct molecular profile associated with mucinous epithelial ovarian cancer
VA Heinzelmann-Schwarz et al.
BRITISH JOURNAL OF CANCER (2006)
Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance
FW Wamunyokoli et al.
CLINICAL CANCER RESEARCH (2006)
Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.
T Bonome et al.
CANCER RESEARCH (2005)
Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer
KK Zorn et al.
CLINICAL CANCER RESEARCH (2005)
Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling
V Ouellet et al.
ONCOGENE (2005)
Histologic type, organ of origin, and Wnt pathway status: Effect on gene expression in ovarian and uterine carcinomas
KA Shedden et al.
CLINICAL CANCER RESEARCH (2005)
Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling
CB Gilks et al.
GYNECOLOGIC ONCOLOGY (2005)
Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential
I Meinhold-Heerlein et al.
ONCOGENE (2005)
Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: Workshop perspectives
DA Bell et al.
HUMAN PATHOLOGY (2004)
Cancer of the ovary
SA Cannistra
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease
CM Ho et al.
GYNECOLOGIC ONCOLOGY (2004)
In vitro chemoresistance and biomarker profiles are unique for histologic subtypes of epithelial ovarian cancer
NG Cloven et al.
GYNECOLOGIC ONCOLOGY (2004)
Gene expression profiling of epithelial ovarian tumours correlated with malignant potential
Susanne Warrenfeltz et al.
MOLECULAR CANCER (2004)
Pathology of ovarian carcinoma
JD Seidman et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2003)
Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells
SM Ho et al.
ONCOGENE (2003)
Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma
AA Jazaeri et al.
MOLECULAR CARCINOGENESIS (2003)
Assisted reproduction in patients with early-stage ovarian malignancies
MP Steinkampf et al.
FERTILITY AND STERILITY (2003)
Long-term follow-up confirm's a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer
MJ Piccart et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2003)
Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38)
JF Gagné et al.
MOLECULAR PHARMACOLOGY (2002)
Ovulation-induced DNA damage in ovarian surface epithelial cells of ewes: Prospective regulatory mechanisms of repair/survival and apoptosis
WJ Murdoch et al.
BIOLOGY OF REPRODUCTION (2001)
Genomic approaches to the pathogenesis of hematologic malignancy
TR Golub
CURRENT OPINION IN HEMATOLOGY (2001)
Precursor lesions of ovarian epithelial malignancy
KM Feeley et al.
HISTOPATHOLOGY (2001)
分享论文
